InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (1 ops.)
Insider track record
Board DirectorDisclosed buys
1
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the complete record of transactions filed by Bakewell John K, Director. Officer active across 4 companies, notably Neuronetics, Inc.. In total, 16 filings have been published. Split: 1 buy · 1 sell. Total volume traded: €587k. History available since 15 August 2021. The latest transaction was filed on 15 August 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Bakewell John K
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations16 total
215,517 shares0Common StockSEC:0001183553-26-000001:0
158,228 shares0Common StockSEC:0001183553-25-000005:0
158,228 shares0Common StockSEC:0001183553-25-000006:0
23,917 shares0Common StockSEC:0000950170-25-075888:0
162,162 shares0Common StockSEC:0001235802-24-000067:0
15,091 shares0Common StockSEC:0000950170-24-063617:0
130,000 shares@ US$4.574100.0% of flowCommon StockSEC:0000950170-24-058974:0
Canonical exit: 8 Aug 2024 (T+90)
145,180 shares0Common StockSEC:0001235802-23-000090:0
14,400 shares@ US$2.70100.0% of flowCommon StockSEC:0001062993-23-012301:0
2,753 shares0Common StockSEC:0001209191-23-032354:0
215,415 shares0Common Stock, $0.000001 par valueSEC:0001235802-22-000097:0
38,910 sharesCommon StockSEC:0001062993-22-013871:0
2,295 shares0Common StockSEC:0001567619-22-011340:0
85,337 shares0Common Stock, $0.000001 par valueSEC:0001235802-21-000107:0
7,137 sharesCommon StockSEC:0001062993-21-005247:0
83,500 sharesCommon StockSEC:0000899243-16-010652:0
16 of 16 declarations
About Bakewell John K
BAKEWELL JOHN K is an Administrateur. He has 15 filings in total, and the sampled recent filings cover the period from 2016-01-04 to 2025-11-18, with buys of EUR 551332 and sells of EUR 36143. He is linked to Xtant Medical Holdings, Inc., Treace Medical Concepts, INC., Neuronetics, Inc. and Lantheus Holdings, Inc., where his listed role is CFO and Treasurer.
